Abstract
In this paper, I shall mainly consider the second part of the question: Not so much who defines quality of life; we know that it has been or can be done by several categories: philosophers, social scientists, physicians, companies (especially pharmaceutical companies), health administration, government ... But rather who makes medical-decisions and how determination of quality of life and other determinants may contribute to a medical decision (1). Medical decisions are mainly made by physicians, but through quality of life or other determinants, the other categories contribute to this decision.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Moinpour CM., Feigl P., Metch B., Hayden KA., Meyskens FL., Crowley J.: Quality of life end points in cancer clinical trials: review and recommendations. Journal of the National Cancer Institute. 1989, 81: 485–495.
O’Connor AMC., Boyd NF., Warde P., Stolbach L., Till JE: Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation tehcnique and treatment experience on preferences. Journal of Chronic Diseases. 1985, 40: 811–815.
Torrance GW., Feeny D.: Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care. 1989, 5: 559–575.
Zittoun R., Mandelli F., Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New England Journal of Medicine 1995, 332: 217–223.
Zittoun R., Suciu S., Solbu G et al. Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - allogeneic or autologous - or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8 A study. Blood 1995, 86, supp’. I: 433a.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zittoun, R. (1997). Quality of Life as a Major Determinant of Medical Decision-Making. In: Levy, J.A., Jasmin, C., Bez, G. (eds) Cancer, AIDS, and Quality of Life. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9570-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9570-7_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9572-1
Online ISBN: 978-1-4757-9570-7
eBook Packages: Springer Book Archive